Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schnittger

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Leukemia|July 29, 2000
Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1C Wuchter, J Harbott, C Schoch, et al.
Leukemia|January 29, 2011
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of casesV Grossmann, A Kohlmann, M Zenger, et al.
Leukemia|September 24, 2013
The role of different genetic subtypes of CEBPA mutated AMLA Fasan, C Haferlach, T Alpermann, et al.
Leukemia|July 18, 2013
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patientsS Weissmann, A Roller, S Jeromin, et al.
Leukemia|November 26, 2011
Landscape of TET2 mutations in acute myeloid leukemiaS Weissmann, T Alpermann, V Grossmann, et al.
Blood Cancer Journal|January 14, 2014
BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemiaS Weber, T Alpermann, F Dicker, et al.
Leukemia|January 31, 2014
Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, E Lippert, A S Harutyunyan, et al.
Leukemia|May 8, 2013
Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristicsV Grossmann, U Bacher, C Haferlach, et al.
Leukemia|September 13, 2014
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL statusM Schmidt, J Rinke, V Schäfer, et al.
Leukemia|April 19, 2013
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, T Alpermann, M Wulfert, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Leukemia|July 29, 2000
Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1C Wuchter, J Harbott, C Schoch, et al.
Leukemia|January 29, 2011
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of casesV Grossmann, A Kohlmann, M Zenger, et al.
Leukemia|September 24, 2013
The role of different genetic subtypes of CEBPA mutated AMLA Fasan, C Haferlach, T Alpermann, et al.
Leukemia|July 18, 2013
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patientsS Weissmann, A Roller, S Jeromin, et al.
Leukemia|November 26, 2011
Landscape of TET2 mutations in acute myeloid leukemiaS Weissmann, T Alpermann, V Grossmann, et al.
Blood Cancer Journal|January 14, 2014
BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemiaS Weber, T Alpermann, F Dicker, et al.
Leukemia|January 31, 2014
Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, E Lippert, A S Harutyunyan, et al.
Leukemia|May 8, 2013
Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristicsV Grossmann, U Bacher, C Haferlach, et al.
Leukemia|September 13, 2014
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL statusM Schmidt, J Rinke, V Schäfer, et al.
Leukemia|April 19, 2013
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, T Alpermann, M Wulfert, et al.
Pageof 14